Michael A. Tartell

1.0k total citations
7 papers, 304 citations indexed

About

Michael A. Tartell is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Michael A. Tartell has authored 7 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 2 papers in Epidemiology and 2 papers in Immunology. Recurrent topics in Michael A. Tartell's work include Viral Infections and Vectors (4 papers), interferon and immune responses (2 papers) and Viral Infections and Outbreaks Research (2 papers). Michael A. Tartell is often cited by papers focused on Viral Infections and Vectors (4 papers), interferon and immune responses (2 papers) and Viral Infections and Outbreaks Research (2 papers). Michael A. Tartell collaborates with scholars based in United States and Spain. Michael A. Tartell's co-authors include Kristi L. Berger, Tristan X. Jordan, Sean M. Kelly, Glenn Randall, Sara Cherry, Debasis Panda, Brent A. Hackett, Kaycie C. Hopkins, Scott E. Hensley and Ari Yasunaga and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Virology.

In The Last Decade

Michael A. Tartell

6 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael A. Tartell United States 6 125 81 80 60 57 7 304
Efraín E. Rivera-Serrano United States 11 187 1.5× 68 0.8× 101 1.3× 97 1.6× 158 2.8× 13 420
Ruidong Hao China 8 186 1.5× 183 2.3× 110 1.4× 82 1.4× 82 1.4× 14 376
Ok-Kyu Song South Korea 9 321 2.6× 100 1.2× 115 1.4× 45 0.8× 27 0.5× 12 460
Vanessa Meier‐Stephenson Canada 10 163 1.3× 102 1.3× 69 0.9× 20 0.3× 46 0.8× 23 310
Ju-Il Kang South Korea 9 93 0.7× 95 1.2× 106 1.3× 65 1.1× 193 3.4× 13 391
Itsuki Hamamoto Japan 7 145 1.2× 239 3.0× 234 2.9× 130 2.2× 75 1.3× 12 481
Grace Naswa Makokha Japan 12 279 2.2× 203 2.5× 152 1.9× 110 1.8× 62 1.1× 24 559
Erik M. Lenarcic United States 12 214 1.7× 121 1.5× 24 0.3× 111 1.9× 68 1.2× 20 389
Adriana Ahumada United States 12 336 2.7× 108 1.3× 78 1.0× 108 1.8× 51 0.9× 20 548
Markus Fricke Germany 10 197 1.6× 55 0.7× 54 0.7× 39 0.7× 151 2.6× 15 380

Countries citing papers authored by Michael A. Tartell

Since Specialization
Citations

This map shows the geographic impact of Michael A. Tartell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Tartell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Tartell more than expected).

Fields of papers citing papers by Michael A. Tartell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Tartell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Tartell. The network helps show where Michael A. Tartell may publish in the future.

Co-authorship network of co-authors of Michael A. Tartell

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Tartell. A scholar is included among the top collaborators of Michael A. Tartell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Tartell. Michael A. Tartell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Mahoney, Matthew, Elizabeth Weiland, Zhenfu Han, et al.. (2025). Inhibitors of membrane associated serine proteases block replication of coronavirus SARS-CoV-2 and influenza virus H1N1. European Journal of Medicinal Chemistry. 302(Pt 3). 118385–118385.
2.
Tartell, Michael A., et al.. (2021). Methylation of viral mRNA cap structures by PCIF1 attenuates the antiviral activity of interferon-β. Proceedings of the National Academy of Sciences. 118(29). 27 indexed citations
3.
Hackett, Brent A., Ari Yasunaga, Debasis Panda, et al.. (2015). RNASEK is required for internalization of diverse acid-dependent viruses. Proceedings of the National Academy of Sciences. 112(25). 7797–7802. 47 indexed citations
4.
Hopkins, Kaycie C., Michael A. Tartell, Christin Herrmann, et al.. (2015). Virus-induced translational arrest through 4EBP1/2-dependent decay of 5′-TOP mRNAs restricts viral infection. Proceedings of the National Academy of Sciences. 112(22). E2920–9. 43 indexed citations
5.
Panda, Debasis, et al.. (2015). The Transcription Factor FoxK Participates with Nup98 To Regulate Antiviral Gene Expression. mBio. 6(2). 20 indexed citations
6.
Lang, Sabine M., et al.. (2013). Kaposi’s Sarcoma-Associated Herpesvirus K3 and K5 Proteins Down Regulate Both DC-SIGN and DC-SIGNR. PLoS ONE. 8(2). e58056–e58056. 17 indexed citations
7.
Berger, Kristi L., Sean M. Kelly, Tristan X. Jordan, Michael A. Tartell, & Glenn Randall. (2011). Hepatitis C Virus Stimulates the Phosphatidylinositol 4-Kinase III Alpha-Dependent Phosphatidylinositol 4-Phosphate Production That Is Essential for Its Replication. Journal of Virology. 85(17). 8870–8883. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026